相关实验视频

Updated: Jun 17, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

多发性骨髓瘤外体miRNAs抑制cGAS-STING抗病毒免疫力

Xin Chen¹, Liwen Wang¹, Qian Cheng¹

¹Department of Hematology, the Third Xiangya Hospital of Central South University, Changsha 412000, China.

Biochimica et biophysica acta. Molecular basis of disease

|August 12, 2024

概括

多发性骨髓瘤细胞通过外体转移微RNA (miRNA),以抑制单细胞抗病毒防御. 针对这些特定的miRNAs提供了一种新的治疗策略,用于预防多发性骨髓瘤患者的DNA病毒感染.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
在瘤学瘤学.

背景情况:

多发性骨髓瘤 (MM) 患者对DNA病毒感染的敏感性增加.
单细胞功能障碍与MM相关的传染性并发症有关,但潜在的机制尚不清楚.

研究的目的:

阐明多发性髓瘤细胞损害单细胞抗病毒免疫力的分子机制.
为了确定参与这种免疫抑制的特定微RNA (miRNA).
评估针对这些miRNA的潜在治疗策略.

主要方法:

从多发性骨髓瘤 (MM) 患者的骨髓中获得的外体内微RNA (miRNA) 的分析.
使用MM细胞系和MM携带的小鼠模型进行体外和体内研究 (C57BL/KaLwRijHsd).
使用对抗组Rs对特定miRNAs的沉默,以评估对病毒复制和先天免疫反应的影响.

主要成果:

多发性骨髓瘤 (MM) 细胞通过外体转移微RNA (miRNA) 到单细胞/巨细胞,抑制先天性抗病毒反应.
在MM衍生的外体中丰富的5种特定的miRNA被确定为cGAS-STING抗病毒通路的负调节者.
在小鼠模型中,通过对抗基因R对这些miRNA进行沉默,显著减少了DNA病毒的复制.

结论:

多发性骨髓瘤 (MM) 细胞通过外体miRNA转移积极抑制宿主天生的抗病毒免疫力.
在MM患者中准异常miRNA表达是一种有前途的治疗方法,可以增强抗病毒防御.
结合miRNA评分和临床因素的预测模型可以评估MM患者的DNA病毒感染易感性.

关键词:

抗病毒免疫抗病毒免疫多发性骨髓瘤是一种多发性骨髓瘤.新诊断是一个新的诊断.预测预后预测预测风险因素风险因素 cGAS-STING 的使用情况.在 miRNA 分数中,分数为

更多相关视频

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...